Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART)
2013-003559-39Phase 4Unknown
- Sponsor
- University of Dundee
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of allopurinol in coronary arteriosclerosis, angina pectoris and myocardial infarction (MI) (2 arms), sponsored by University of Dundee. Primary endpoint: Composite cardiovascular endpoint (APTC). Status: unknown.
02
Drugs
allopurinol
03
Conditions
coronary arteriosclerosisangina pectorismyocardial infarction (MI)
Beyond the preview
Go deeper on 2013-003559-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003559-39.